Avantor, Inc. $AVTR Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in Avantor, Inc. (NYSE:AVTR) by 5.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,806,512 shares of the company’s stock after buying an additional 91,254 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.26% of Avantor worth $22,545,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of AVTR. EverSource Wealth Advisors LLC lifted its position in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new position in Avantor during the 2nd quarter valued at about $32,000. Osaic Holdings Inc. grew its position in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the last quarter. Farther Finance Advisors LLC grew its position in Avantor by 172.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock worth $46,000 after purchasing an additional 2,346 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on AVTR shares. UBS Group reiterated a “neutral” rating and set a $10.50 price objective on shares of Avantor in a research report on Thursday, February 12th. Morgan Stanley set a $10.00 target price on Avantor in a research report on Friday, February 13th. Jefferies Financial Group reiterated an “underperform” rating and set a $8.00 price target on shares of Avantor in a research report on Thursday, February 12th. Wells Fargo & Company decreased their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Finally, Robert W. Baird set a $11.00 price target on Avantor in a report on Thursday, February 12th. Three investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $11.80.

Insider Buying and Selling at Avantor

In related news, Director Sanjeev K. Mehra purchased 125,000 shares of the company’s stock in a transaction on Tuesday, March 10th. The shares were bought at an average price of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the acquisition, the director owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. This represents a 35.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gregory T. Lucier acquired 50,000 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were bought at an average price of $9.16 per share, with a total value of $458,000.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately $458,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 275,000 shares of company stock valued at $2,399,250. Corporate insiders own 1.20% of the company’s stock.

Avantor Stock Performance

NYSE:AVTR opened at $7.73 on Wednesday. Avantor, Inc. has a twelve month low of $7.38 and a twelve month high of $16.54. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average of $9.73 and a 200-day moving average of $11.39. The firm has a market cap of $5.27 billion, a price-to-earnings ratio of -9.90, a price-to-earnings-growth ratio of 2.98 and a beta of 0.97.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 11th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm earned $0.27 EPS. The business’s revenue for the quarter was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.